Log In
BCIQ
Print this Print this
 

RBL001/RBL002

  Manage Alerts
Collapse Summary General Information
Company BioNTech AG
DescriptionRNA-based cancer vaccine targeting two tumor-associated antigens
Molecular Target
Mechanism of ActionImmunotherapy
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPhase I
Standard IndicationMelanoma
Indication DetailsTreat advanced melanoma
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today